Shu-Chien Liu

Title: Innovations of Shu-Chien Liu

Introduction

Shu-Chien Liu is a notable inventor based in Taipei County, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions. With a total of 2 patents, his work focuses on improving drug delivery systems and enhancing the bioavailability of therapeutic agents.

Latest Patents

One of his latest patents is the "Sustained Release Implant for Granisetron." The main goals of this invention are to develop a long-term release of Granisetron injection implant composition using biodegradable polymers and to refine the processing methods involved. Granisetron is combined with various biodegradable polymers, and a hot melt extrusion technique is employed, adjusting parameters such as diameter, temperature, extrusion rate, and holding time to create the implant. In vitro dissolution studies indicate that the Granisetron injection implant composition can release the drug continuously for over 7 days.

Another significant patent is the "Aqueous Inhalation Pharmaceutical Composition." This invention comprises a polypeptide or protein and aims to improve the bioavailability of these compounds while minimizing toxicity in the lungs. This innovative approach has the potential to enhance therapeutic outcomes for patients requiring inhalation therapies.

Career Highlights

Shu-Chien Liu is associated with the Development Center for Biotechnology, where he applies his expertise in drug formulation and delivery systems. His work has been instrumental in advancing the field of biotechnology and improving patient care through innovative solutions.

Collaborations

He has collaborated with notable colleagues, including Fan-Jung Liu and Paonien Chan, contributing to various projects that aim to push the boundaries of pharmaceutical science.

Conclusion

Shu-Chien Liu's contributions to biotechnology through his patents and collaborative efforts highlight his commitment to innovation in drug delivery systems. His work continues to impact the field positively, paving the way for future advancements in pharmaceutical compositions.